Alambic Investment Management, L.P. - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$196,000
+10.1%
19,934
+11.4%
2.15%
+382.1%
Q2 2020$178,000
+12.7%
17,9000.0%0.45%
+16.8%
Q1 2020$158,000
-19.8%
17,900
-16.0%
0.38%
+131.5%
Q4 2019$197,00021,3160.16%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 1,050,124$10,312,0003.31%
Alambic Investment Management, L.P. 19,934$196,0002.15%
INGALLS & SNYDER LLC 1,363,603$13,391,0000.92%
ACUTA CAPITAL PARTNERS, LLC 300,000$2,946,0000.80%
RA Capital Management 1,858,474$18,250,0000.33%
Perceptive Advisors 2,150,641$21,119,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 310,000$3,044,0000.30%
Eversept Partners, LP 103,829$1,019,6010.23%
Opaleye Management Inc. 100,000$982,0000.19%
GSA CAPITAL PARTNERS LLP 58,095$570,0000.10%
View complete list of CONCERT PHARMACEUTICALS INC shareholders